Trapa bispinosa Roxb. Pericarp Extract Exerts 5α-Reductase Inhibitory Activity in Castrated Benign Prostatic Hyperplasia Model Mice

Int J Mol Sci. 2023 Jul 21;24(14):11765. doi: 10.3390/ijms241411765.

Abstract

Trapa bispinosa Roxb. pericarp extract (TBE) has a polyphenol-rich composition and exhibits potent antioxidant and anti-glycation activities in vitro. In the present study, we investigated the inhibitory effects of TBE on 5α-reductase in vitro using LNCaP cells and in vivo using a mouse model of castrated benign prostatic hyperplasia. TBE showed concentration-dependent inhibitory effects in the 5α-reductase (5αR) activity assay. In a reporter assay using AR-Luc/LNCaP cells, TBE inhibited the activity induced by testosterone, but not that induced by dihydrotestosterone. TBE also suppressed prostate cell proliferation, prostate-specific antigens, and transmembrane protease serine 2 expression in a castrated benign prostatic hyperplasia mouse model. In addition, ellagic acid, but not gallic acid, decreased 5αR and AR-Luc activities. Together, these results suggest a potential role for TBE in benign prostatic hyperplasia through inhibition of 5αR.

Keywords: 5α-reductase; Trapa bispinosa Roxb. pericarp extract; androgen receptor; hyperplasia; prostate.

MeSH terms

  • Cholestenone 5 alpha-Reductase
  • Dihydrotestosterone / metabolism
  • Humans
  • Male
  • Prostatic Hyperplasia* / chemically induced
  • Prostatic Hyperplasia* / drug therapy
  • Testosterone / metabolism

Substances

  • Cholestenone 5 alpha-Reductase
  • Testosterone
  • Dihydrotestosterone

Supplementary concepts

  • Trapa

Grants and funding

This research received no external funding.